Future Directions in Tumor Immunology
7 月 14, 2026Core Framework & Diagram How Does the Immune System Recognize Cancer Cells?
7 月 14, 2026
1 minuete Read
How Does the Immune System Recognize Cancer Cells?
Your body produces potential cancer cells every day — here's how the immune system finds them
编辑部精选 · 一分钟理解
This surprises most people: your body generates cells with cancer-causing mutations every single day. Yet most of the time, your immune system eliminates them before you ever feel a thing.
This process is called immune surveillance. NK cells and T cells patrol the entire body continuously, scanning cell surface signals. Normal cells carry a set of normal identity markers. Cells undergoing malignant transformation display abnormal markers. The immune system detects those abnormalities and launches clearance.
When gaps appear in this surveillance system, cancer finds its opening. This is a central immunological explanation for why cancer risk rises sharply after forty as immune function declines.
核心要点
01
Immune surveillance is your body's daily invisible cancer-prevention operation: NK cells and CD8+ T cells clear large numbers of early cancer cells daily, you feel nothing. Most potential cancer cells are terminated at the earliest stage.
02
NK cells use two signals to judge whether a cell is malignant: reduced MHC-I (lost self-identification) + NKG2D ligand appearance (stress distress signal). Both together are the typical profile of early cancer cells. An 11-year follow-up study confirms low NK activity → significantly higher cancer risk.
03
CD8+ T cells use 'neoantigens' to precisely identify cancer cells: mutant proteins produced by cancer through MHC-I presentation; T cells recognize this peptide absent in normal cells and precisely kill them without harming surrounding normal cells.
04
Three major tumor evasion strategies: downregulate MHC-I (hide from T cells), express PD-L1 (apply T cell brakes), secrete TGF-β/recruit Tregs (build immunosuppressive microenvironment). This is the complete logic behind PD-1 inhibitor therapy.
05
Post-fifty cancer risk rises exponentially — the combined result of 'mutation accumulation' and 'immune surveillance capacity declining.' Regular exercise (maintaining NK cell activity) and low-inflammation lifestyle are the core means of maintaining daily cancer prevention capacity.
推荐阅读
